OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
1063
Results
Show all
Save search
Copy query
Show results for
Unknown
(989)
Genomics
(33)
Proteomics
(23)
Metabolomics
(13)
Transcriptomics
(5)
Organisms
Caenorhabditis elegans
(22)
Homo sapiens
(17)
Andropogon gerardi
(16)
Bacteria
(16)
Botrytis cinerea
(16)
Canis lupus familiaris
(16)
Clostridium perfringens
(16)
Cnidaria
(16)
Cricetulus griseus
(16)
Eukaryota
(16)
Fasciola
(16)
Hepatitis B virus
(16)
Human betaherpesvirus 5
(16)
Japanese encephalitis virus group
(16)
Mesocricetus auratus
(16)
Miscanthus x giganteus
(16)
Mycobacterium tuberculosis
(16)
Orthoflavivirus
(16)
Panicum virgatum
(16)
Platyhelminthes
(16)
Pseudomonas aeruginosa AES-1R
(16)
Rickettsia
(16)
Saccharomyces cerevisiae
(16)
Schizosaccharomyces pombe
(16)
Severe acute respiratory syndrome coronavirus 2
(16)
Shigella
(16)
Sorghastrum nutans
(16)
Mus musculus
(3)
Bos grunniens
(1)
Arabidopsis thaliana
(1)
Repository
biostudies-arrayexpress
(27)
pride
(16)
MetaboLights
(12)
EGA
(11)
iProX
(6)
GNPS
(1)
PeptideAtlas
(1)
Tissue
Hepatocyte
(3)
Cell culture
(2)
Epithelial cell
(2)
Whole body
(2)
Blood
(1)
Blood serum
(1)
Cerebrospinal fluid
(1)
Heart
(1)
Hepatoma cell line
(1)
Liver
(1)
Malignant cell
(1)
Disease
Colon cancer
(2)
Liver cancer
(2)
High bone mineral density
(1)
IgA glomerulonephritis
(1)
Mixed disorder as reaction to stress
(1)
Myocardial ischemia
(1)
Technology Type
Mass Spectrometry
(16)
Mass spectrometry
(8)
Shotgun proteomics
(8)
Mass spectrometry assay
(3)
Affinity proteomics
(2)
Data-dependent acquisition
(2)
Olink affinity proteomics
(2)
Illumina Genome Analyzer II, Illumina HiSeq 2000
(1)
NMR spectroscopy
(1)
Affinity purification coupled with mass spectrometry proteomics
(1)
Chemical cross-linking coupled with mass spectrometry proteomics
(1)
DiaPASEF
(1)
Gel-based experiment
(1)
Instrument Platform
Liquid Chromatography MS - negative - reverse phase
(8)
Liquid Chromatography MS - positive - reverse phase
(6)
Liquid Chromatography MS - positive - hilic
(3)
Liquid Chromatography MS - - reverse phase
(2)
MicrOTOF-Q II
(1)
Q Exactive
(1)
Wates I-Class/XEVO-G2 XS QTOF
(1)
Bruker
(1)
Xevo G2 QTOF (Waters)
(1)
Liquid Chromatography MS - negative - hilic
(1)
LCQ Classic
(1)
Publication Date
2011
(22)
2025
(6)
2023
(5)
2019
(5)
2026
(4)
2024
(4)
2021
(3)
2020
(2)
2015
(1)
2014
(1)
2013
(1)
2012
(1)
2007
(1)
2022
(1)
2018
(1)
2017
(1)
2004
(1)
UNIPROT ID/AC
P06208-2
(1)
CHEBI ID
CHEBI:28834
(4)
CHEBI:16359
(4)
CHEBI:6650
(4)
CHEBI:17368
(4)
CHEBI:16857
(3)
CHEBI:17203
(3)
CHEBI:17196
(3)
CHEBI:545687
(3)
CHEBI:16566
(3)
CHEBI:73060
(3)
CHEBI:22652
(3)
CHEBI:17053
(3)
CHEBI:15891
(3)
CHEBI:17482
(3)
CHEBI:18019
(3)
CHEBI:15971
(3)
CHEBI:16708
(3)
CHEBI:17568
(3)
CHEBI:16015
(3)
CHEBI:16704
(3)
CHEBI:15741
(3)
CHEBI:17115
(3)
CHEBI:16196
(3)
CHEBI:16919
(3)
CHEBI:15354
(3)
CHEBI:17895
(3)
CHEBI:17295
(3)
CHEBI:16828
(3)
CHEBI:18089
(3)
CHEBI:34772
(2)
Metabolite Name
Chenodeoxycholic Acid
(3)
Hippuric acid
(3)
N-Acetylleucine
(2)
Glycochenodeoxycholic acid
(2)
2-oxophytanic acid
(2)
Palmitic amide
(2)
Lithocholic acid
(2)
N-Acetyl-L-methionine
(2)
Ornithine
(2)
7-Ketocholesterol
(2)
LPE 18:3
(2)
LPE 18:2
(2)
Eicosapentaenoic acid
(2)
LPE 18:1
(2)
Alpha-Ketoglutaric acid
(2)
Pantothenic acid
(2)
LPE 16:0
(2)
Taurine
(2)
Cyclohexaneacetic acid
(2)
LPC 18:1
(2)
Deoxycholic acid
(2)
Cholic acid
(2)
Arachidonic acid
(2)
Cis-Aconitic acid
(2)
Theophylline
(2)
Cyclamic acid
(2)
Stearic acid
(2)
Cis-5-Tetradecenoylcarnitine
(2)
Uracil
(2)
Xanthosine
(2)
Modification
Not available
(1)
Study type
ChIP-seq
(22)
RNA-seq of coding RNA
(3)
Transcription profiling by array
(1)
RNA-seq of non coding RNA
(1)
Release Date
2025
(175)
2024
(154)
2023
(139)
2022
(126)
2021
(111)
2020
(65)
2019
(53)
2017
(34)
2018
(28)
2011
(24)
2026
(23)
2016
(23)
2015
(21)
2014
(16)
2013
(8)
2012
(6)
2007
(2)
2010
(2)
2009
(2)
2005
(1)
2002
(1)
2001
(1)
2000
(1)
Lab affiliation
National Key Laboratory of Medical Molecular Biology & Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
(2)
The First Affiliated Hospital of Fujian Medical University
(2)
University of Science and Technology of China
(2)
1 Affiliated Hangzhou First People’s Hospital, State Key Laboratory of Medical Proteomics, School of Medicine, School of Future Biomedicine, Westlake University, Hangzhou, Zhejiang Province, China. 2 Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang Province, China. 3 Research Center for Industries of the Future, School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China.
(1)
1. Department of Pharmacology (National Key Laboratory of Frigid Zone Cardiovascular Disease, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University
(1)
China National GenBank,BGI-Shenzhen,Shenzhen 518120,China
(1)
Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China
(1)
Department of Nephrology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China;Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases; Guangzhou, China.
(1)
Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine
(1)
Laboratory of Genetics, University of Wisconsin-Madison, Madison, WI, USA Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, WI, USA
(1)
School of Medicine and Institutes for Life Sciences, South China University of Technology,Guangzhou, China
(1)
Shanghai Veterinary Research Institute, Chinese Academy of Agriculture Sciences, Shanghai, China
(1)
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510182, China
(1)
Previous
page
1 / 107
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
107
Next
page
Sort
by:
Relevance
Page size
10
Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.
Not available
S-EPMC5690380
|
biostudies-literature
Cite
Identification of immune-related molecular markers in intracranial aneurysm (IA) based on machine learning and cytoscape-cytohubba plug-in.
Not available
S-EPMC10088219
|
biostudies-literature
Cite
Genome-wide miRNA profile of MCF7 cells overexpressing wild-type and mutant miR-222
MCF7 cells were infected with retrovirus to overexpress wild-type and mutant miR-222 Measure miRNA expression level in MCF7 cells after overexpressing wild-type and mutant miR-222
ORGANISM(S):
Homo sapiens
2015-02-05
|
E-GEOD-64363
|
biostudies-arrayexpress
Cite
Defect-modulated oxygen adsorption and Z-scheme charge transfer for highly selective H<sub>2</sub>O<sub>2</sub> photosynthesis in pure water.
Not available
S-EPMC12504443
|
biostudies-literature
Cite
Prior bariatric surgery and perioperative cardiovascular outcomes following noncardiac surgery in patients with type 2 diabetes mellitus: hint from National Inpatient Sample Database.
Not available
S-EPMC7339406
|
biostudies-literature
Cite
CircCRIM1 Ameliorates Endothelial Cell Angiogenesis in Aging through the miR-455-3p/Twist1/VEGFR2 Signaling Axis.
Not available
S-EPMC9569221
|
biostudies-literature
Cite
RNA-Seq and WGCNA Analyses Reveal Key Regulatory Modules and Genes for Salt Tolerance in Cotton.
Not available
S-EPMC11431110
|
biostudies-literature
Cite
Blocking Dectin-1 prevents colorectal tumorigenesis by suppressing prostaglandin E2 production in myeloid-derived suppressor cells and enhancing IL-22 binding protein expression.
Not available
S-EPMC10023663
|
biostudies-literature
Cite
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria.
Not available
S-EPMC9661708
|
biostudies-literature
Cite
Development and evaluation of vaccination strategies for addressing the continuous evolution SARS-CoV-2 based on recombinant trimeric protein technology: Potential for cross-neutralizing activity and broad coronavirus response.
Not available
S-EPMC11324815
|
biostudies-literature
Cite
Previous
page
1 / 107
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
107
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
